Tumor initiating cells in esophageal squamous cell carcinomas express high levels of CD44.
BACKGROUND: Esophageal Squamous Cell Carcinoma (ESCC) is a major subtype of esophageal cancer causing significant morbility and mortality in Asia. Mechanism of initiation and progression of this disease is unclear. Tumor initiating cells (TICs) are the subpopulation of cells which have the ability t...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2011-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC3123317?pdf=render |
| _version_ | 1828414775000825856 |
|---|---|
| author | Jiang-Sha Zhao Wen-Jie Li Di Ge Pei-Jing Zhang Jing-Jing Li Chun-Lai Lu Xiao-Dan Ji Dong-Xian Guan Hong Gao Li-Yan Xu Eng-Ming Li Harmik Soukiasian H Phillip Koeffler Xiao-Fan Wang Dong Xie |
| author_facet | Jiang-Sha Zhao Wen-Jie Li Di Ge Pei-Jing Zhang Jing-Jing Li Chun-Lai Lu Xiao-Dan Ji Dong-Xian Guan Hong Gao Li-Yan Xu Eng-Ming Li Harmik Soukiasian H Phillip Koeffler Xiao-Fan Wang Dong Xie |
| author_sort | Jiang-Sha Zhao |
| collection | DOAJ |
| description | BACKGROUND: Esophageal Squamous Cell Carcinoma (ESCC) is a major subtype of esophageal cancer causing significant morbility and mortality in Asia. Mechanism of initiation and progression of this disease is unclear. Tumor initiating cells (TICs) are the subpopulation of cells which have the ability to self-renew, as well as, to drive initiation and progression of cancer. Increasing evidence has shown that TICs exist in a variety of tumors. However, the identification and characterization of TICs in esophageal carcinoma has remained elusive. METHODOLOGY/PRINCIPAL FINDINGS: to identify TICs in ESCC, ESCC cell lines including two primary cells were used for screening suitable surface marker. Then colony formation assay, drug resistant assay and tumorigenicity assay in immune deficient mice were used to characterize TICs in ESCC. We found that just the CD44 expression correlated with tumorigenicity in ESCC cell lines. And then induced differentiation of ESCC cells by all-trans retinoic acid treatment led to decreased expression of CD44. The FACS isolated cell subpopulations with high CD44 expression showed increased colony formation and drug resistance in vitro, as well as significantly enhanced tumorigenicity in NOD/SICD mice, as compared to the low expressing CD44 ESCC cells. CONCLUSIONS/SIGNIFICANCE: our study has discovered a novel TIC surface marker, CD44, which can be utilized to enrich efficiently the TICs in ESCC. These findings will be useful for further studies of these cells and exploring therapeutic approaches. |
| first_indexed | 2024-12-10T13:32:28Z |
| format | Article |
| id | doaj.art-77e68649a5e04f40bf69c15baa13e464 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-10T13:32:28Z |
| publishDate | 2011-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-77e68649a5e04f40bf69c15baa13e4642022-12-22T01:46:55ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-0166e2141910.1371/journal.pone.0021419Tumor initiating cells in esophageal squamous cell carcinomas express high levels of CD44.Jiang-Sha ZhaoWen-Jie LiDi GePei-Jing ZhangJing-Jing LiChun-Lai LuXiao-Dan JiDong-Xian GuanHong GaoLi-Yan XuEng-Ming LiHarmik SoukiasianH Phillip KoefflerXiao-Fan WangDong XieBACKGROUND: Esophageal Squamous Cell Carcinoma (ESCC) is a major subtype of esophageal cancer causing significant morbility and mortality in Asia. Mechanism of initiation and progression of this disease is unclear. Tumor initiating cells (TICs) are the subpopulation of cells which have the ability to self-renew, as well as, to drive initiation and progression of cancer. Increasing evidence has shown that TICs exist in a variety of tumors. However, the identification and characterization of TICs in esophageal carcinoma has remained elusive. METHODOLOGY/PRINCIPAL FINDINGS: to identify TICs in ESCC, ESCC cell lines including two primary cells were used for screening suitable surface marker. Then colony formation assay, drug resistant assay and tumorigenicity assay in immune deficient mice were used to characterize TICs in ESCC. We found that just the CD44 expression correlated with tumorigenicity in ESCC cell lines. And then induced differentiation of ESCC cells by all-trans retinoic acid treatment led to decreased expression of CD44. The FACS isolated cell subpopulations with high CD44 expression showed increased colony formation and drug resistance in vitro, as well as significantly enhanced tumorigenicity in NOD/SICD mice, as compared to the low expressing CD44 ESCC cells. CONCLUSIONS/SIGNIFICANCE: our study has discovered a novel TIC surface marker, CD44, which can be utilized to enrich efficiently the TICs in ESCC. These findings will be useful for further studies of these cells and exploring therapeutic approaches.http://europepmc.org/articles/PMC3123317?pdf=render |
| spellingShingle | Jiang-Sha Zhao Wen-Jie Li Di Ge Pei-Jing Zhang Jing-Jing Li Chun-Lai Lu Xiao-Dan Ji Dong-Xian Guan Hong Gao Li-Yan Xu Eng-Ming Li Harmik Soukiasian H Phillip Koeffler Xiao-Fan Wang Dong Xie Tumor initiating cells in esophageal squamous cell carcinomas express high levels of CD44. PLoS ONE |
| title | Tumor initiating cells in esophageal squamous cell carcinomas express high levels of CD44. |
| title_full | Tumor initiating cells in esophageal squamous cell carcinomas express high levels of CD44. |
| title_fullStr | Tumor initiating cells in esophageal squamous cell carcinomas express high levels of CD44. |
| title_full_unstemmed | Tumor initiating cells in esophageal squamous cell carcinomas express high levels of CD44. |
| title_short | Tumor initiating cells in esophageal squamous cell carcinomas express high levels of CD44. |
| title_sort | tumor initiating cells in esophageal squamous cell carcinomas express high levels of cd44 |
| url | http://europepmc.org/articles/PMC3123317?pdf=render |
| work_keys_str_mv | AT jiangshazhao tumorinitiatingcellsinesophagealsquamouscellcarcinomasexpresshighlevelsofcd44 AT wenjieli tumorinitiatingcellsinesophagealsquamouscellcarcinomasexpresshighlevelsofcd44 AT dige tumorinitiatingcellsinesophagealsquamouscellcarcinomasexpresshighlevelsofcd44 AT peijingzhang tumorinitiatingcellsinesophagealsquamouscellcarcinomasexpresshighlevelsofcd44 AT jingjingli tumorinitiatingcellsinesophagealsquamouscellcarcinomasexpresshighlevelsofcd44 AT chunlailu tumorinitiatingcellsinesophagealsquamouscellcarcinomasexpresshighlevelsofcd44 AT xiaodanji tumorinitiatingcellsinesophagealsquamouscellcarcinomasexpresshighlevelsofcd44 AT dongxianguan tumorinitiatingcellsinesophagealsquamouscellcarcinomasexpresshighlevelsofcd44 AT honggao tumorinitiatingcellsinesophagealsquamouscellcarcinomasexpresshighlevelsofcd44 AT liyanxu tumorinitiatingcellsinesophagealsquamouscellcarcinomasexpresshighlevelsofcd44 AT engmingli tumorinitiatingcellsinesophagealsquamouscellcarcinomasexpresshighlevelsofcd44 AT harmiksoukiasian tumorinitiatingcellsinesophagealsquamouscellcarcinomasexpresshighlevelsofcd44 AT hphillipkoeffler tumorinitiatingcellsinesophagealsquamouscellcarcinomasexpresshighlevelsofcd44 AT xiaofanwang tumorinitiatingcellsinesophagealsquamouscellcarcinomasexpresshighlevelsofcd44 AT dongxie tumorinitiatingcellsinesophagealsquamouscellcarcinomasexpresshighlevelsofcd44 |